Increased AKT activation has been noted observed in high-grade and late-stage serous ovarian cancer [47–49], in which AKT exerts anti-apoptotic effects, antagonizes cell cycle arrest, modulates angiogenesis, and activates mRNA translation via mTOR signaling [50]. Here, MTOR is linked to ovarian serous adenocarcinoma.